Egetis Therapeutics AB (publ)

DB:P0F Stock Report

Market Cap: €143.8m

Egetis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:P0F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Jul 23Buy€11,264Henrik KrookIndividual33,594€0.34
06 Jul 23Buy€2,332Christian SonessonIndividual7,000€0.33
04 Jul 23Buy€5,149Nicklas WesterholmIndividual15,350€0.34
15 Jun 23Buy€17,740Gunilla OsswaldIndividual40,000€0.44
05 Jun 23Buy€4,690Elisabeth SvanbergIndividual10,280€0.46
01 Jun 23Buy€2,117Kristina NygrenIndividual5,000€0.42
31 May 23Buy€85,340Mats BlomIndividual200,000€0.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of P0F?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms17,017,2205.82%
Individual Insiders30,241,42610.3%
Private Companies61,976,21121.2%
Institutions70,337,97024%
General Public112,998,63238.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.2%.


Top Shareholders

Top 25 shareholders own 61.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
Cetoros AB
33,776,221€16.6m0%no data
7.61%
Peter Lindell
22,260,000€10.9m0%no data
7.32%
Fourth Swedish National Pension Fund (AP4)
21,404,690€10.5m0%0.05%
6.04%
Avla Holding AB
17,668,330€8.7m0%no data
5.82%
Frazier Life Sciences Management, LP
17,017,220€8.4m0%0.46%
4.8%
Handelsbanken Asset Management
14,039,294€6.9m3.64%0.01%
4.73%
Flerie Invest AB
13,844,458€6.8m4.25%15.69%
3.6%
Recipharm AB (publ)
10,531,660€5.2m0%no data
2.2%
Linc AB
6,432,021€3.2m0%2.21%
1.82%
Avanza Fonder AB
5,335,379€2.6m0%0.08%
1.46%
Unionen, Endowment Arm
4,275,833€2.1m0%0.81%
1.2%
Carl Rosvall
3,520,287€1.7m0%no data
1.07%
Mats Blom
3,134,762€1.5m0%no data
0.49%
SEB Investment Management AB
1,444,910€710.1k0%no data
0.39%
Healthinvest Partners AB
1,129,177€555.0k0%0.28%
0.3%
AXA Investment Managers S.A.
873,955€429.5k0%no data
0.21%
FCG Fonder AB
608,885€299.2k0%0.12%
0.17%
Financiere Arbevel
500,000€245.7k0%0.05%
0.12%
Henrik Krook
339,593€166.9k0%no data
0.1%
Yilmaz Mahshid
303,089€149.0k0%no data
0.097%
Thomas Lonngren
283,248€139.2k0%no data
0.095%
Medical Strategy GmbH, Asset Management Arm
277,000€136.1k0%0.01%
0.079%
Nicklas Westerholm
232,579€114.3k9.2%no data
0.042%
Skandia Fonder AB
122,324€60.1k0%no data
0.017%
Dimensional Fund Advisors LP
50,044€24.6k-0.17%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.